Not a good buy right now: the stock is in a strong downtrend (bearish MAs, worsening MACD) and is breaking/pressing key support around ~1.165.
No Intellectia edge today: both AI Stock Picker and SwingMax show no actionable buy signal, so there’s no quantified setup to justify stepping in immediately.
Fundamentals and flows are not supportive for an impatient entry: latest quarter shows steep YoY revenue decline and deeper losses, while hedge funds are increasing selling.
The pre-market bounce (+5.17%) looks more like a reflex/oversold bounce attempt than a confirmed trend reversal; odds favor more chop/down before any durable recovery.
Momentum: MACD histogram is negative (-0.0287) and expanding lower, signaling selling pressure is strengthening rather than stabilizing.
Oversold: RSI(6) at 15.99 is deeply oversold, which can produce short bounces, but oversold alone is not a reversal signal.
Levels: Current ~1.16 is at/just below S1 (1.165). Next downside support is S2 (1.068). Upside hurdles: pivot 1.321, then R1 1.478.
Pattern-based forward bias (provided): ~-2.08% next week vs +7.39% next month suggests near-term pain risk remains elevated even if a longer bounce is possible.
increases the probability of a short-term relief bounce, especially if price reclaims and holds above ~1.165 then ~1.
Pre-market strength (+5.17%) suggests some dip-buying interest could appear intraday.
Neutral/Negative Catalysts
Hedge fund activity: selling increased ~159.81% QoQ, a notable negative flow signal.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 137.432M, down -46.04% YoY (sharp contraction).
Net income: -65.415M, down -68.21% YoY (losses widened).
EPS: -0.10, down -66.67% YoY.
Gross margin: 7.91, up +145.65% YoY (improving margin, but overall profitability still deeply negative).
Overall takeaway: growth is negative and earnings quality is weak, which typically limits the durability of technical bounces.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target change data was provided, so the recent trend in Wall Street ratings and targets cannot be confirmed.
Practical read given available data: without visible analyst support and with weak fundamentals/negative flows, the pro case is limited to a speculative oversold bounce; the con case (trend + deteriorating financials + hedge fund selling) dominates.
Politicians/congress check: No recent congress trading data available (last 90 days), so there is no confirmable influential buying/selling signal from that channel.
Wall Street analysts forecast LOT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LOT is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast LOT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LOT is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
